Exercise and Neurocognition in Adults Relative to ApoE Genotype
Effects of an Integrated Intervention Program on Neurocognition in Late-Middle-Aged and Older Adults Relative to ApoE Genotypes: An ERP Study
1 other identifier
interventional
120
1 country
2
Brief Summary
The current project is a single-blinded, double-arm, 6-month randomized controlled trial aiming to assess the effects of a integrated intervention program on neurocognitive function with respect to event-related potential in adults aged 45-70 years. Additionally, the potential impacts of apolipoprotein epsilon-4 alleles and the brain-derived neurotrophic factor will be explored.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2021
CompletedFirst Posted
Study publicly available on registry
November 1, 2021
CompletedStudy Start
First participant enrolled
April 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedNovember 27, 2023
November 1, 2023
2.9 years
September 26, 2021
November 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Inhibition: Changes in Stroop test performance
The computerized Stroop test is administrated to assess participants' inhibitory function, and the changes in Stroop test performance from baseline to end of the intervention (i.e., month 6) will be examined.
30 minutes each at the baseline and at month 6
Changes in neuroelectrical activities
The neuroelectrical activities during the computerized cognitive tasks is recorded and analyzed using the Neuroscan system. Changes in the neuroelectrical activities from baseline to end of the intervention (i.e., month 6) will be examined.
60 minutes each at baseline and at month 6
Secondary Outcomes (9)
ApoE genotype
5 minutes at baseline
Blood neurotrophic marker: Changes in brain-derived neurotrophic factor (BDNF) levels
5 minutes each at baseline and at month 6
Physical fitness measurements: Changes in aerobic fitness
30 minutes each at baseline and at month 6
Physical fitness measurements: Changes in muscular fitness
15 minutes each at baseline and at month 6
Physical fitness measurements: Changes in flexibility
15 minutes each at baseline and at month 6
- +4 more secondary outcomes
Study Arms (2)
Integrated Intervention Group (IIG)
EXPERIMENTALThe IIG attends 150 min exercise per week, which consists of one 90-min trainer-supervised program and multiple online sessions, for 6 months. Intervention: aerobic exercise, resistance exercise, coordinative exercise, flexibility, social interaction, and meditation.
Control Group
OTHERThe control group is invited to attend one 60-min online educational course per week for 6 months. Intervention: 60-min online educational program.
Interventions
The IIG attends 150 min exercise per week, which consists of one 90-min trainer-supervised session and multiple online sessions for 6 months. Each session consists of (1) warm-up, (2) resistance exercise and flexibility exercise, (3) resistance exercise and coordinative exercise from the "Eastern exercise" perspective, (4) social interaction exercise, and (5) cool-down and meditation.
The Control Group is informed to maintain their lifestyles and invited to attend one 60-min online educational course per week. The participants are required to provide their physical activity behavior once every month for 6 months (6 times).
Eligibility Criteria
You may qualify if:
- Normal or corrected-to-normal vision
- Able to speak and read Chinese
- Scores of Mini-Mental Status Examination \>= 25
- Physical Activity Readiness Questionnaire score \< 0
- Able to conduct the exercise with moderate intensity
- Provide informed consent
You may not qualify if:
- Diagnosed or self-reported cognitive problems (e.g., mild cognitive impairment or dementia)
- Diagnosed or self-reported physical disease (e.g., untreated hypertension and chronic heart disease, stroke, brain tumor, musculoskeletal disorders, other exercise contradictions)
- Diagnosed or self-reported major psychiatric illness (e.g., major depression, schizophrenia)
- Diagnosed or self-reported neurodegenerative disease (e.g., Alzheimer's disease or other dementias, Parkinson's disease (PD) and PD-related disorders, Huntington's disease)
- History of alcohol or drug abuse
- History of chemotherapy
- Traveling consecutively for three weeks or more during the study
- Unwillingness to be randomized to one of the two groups
- Currently participating in another study trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Yu-Kai Chang
Taipei, 106, Taiwan
Yu-Kai Normal Chang
Taipei, 162, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yu-Kai Chang, PhD
Department of Physical Education and Sport Sciences, National Taiwan Normal University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 26, 2021
First Posted
November 1, 2021
Study Start
April 11, 2022
Primary Completion
March 1, 2025
Study Completion
September 1, 2025
Last Updated
November 27, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share